Justin "Jay" Bader, MD
Hospital ResidentCards
About
Research
Publications
2026
Evolving therapeutics in colorectal cancer peritoneal metastases
Bader J, Aguirre N, Schultz K, Ofori K, Godfrey E, Gupta P, Tseng R, Cecchini M, Sundar R, Turaga K. Evolving therapeutics in colorectal cancer peritoneal metastases. Cancer And Metastasis Reviews 2026, 45: 25. PMID: 42024175, DOI: 10.1007/s10555-026-10335-0.Peer-Reviewed Original ResearchASO Author Reflections: New Insights for Personalized HIPEC Strategies in Colorectal Cancer Peritoneal Metastases
Gupta P, Godfrey E, Schultz K, Qiao L, Aguirre N, Bader J, Foote M, Shen J, Shergill A, Cecchini M, Sundar R, Sheltzer J, Turaga K. ASO Author Reflections: New Insights for Personalized HIPEC Strategies in Colorectal Cancer Peritoneal Metastases. Annals Of Surgical Oncology 2026, 1-2. PMID: 41896510, DOI: 10.1245/s10434-026-19312-x.Peer-Reviewed Original ResearchASO Visual Abstract: Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases
Gupta P, Godfrey E, Schultz K, Qiao L, Aguirre N, Bader J, Foote M, Shen J, Shergill A, Cecchini M, Sundar R, Sheltzer J, Turaga K. ASO Visual Abstract: Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases. Annals Of Surgical Oncology 2026, 1-2. PMID: 41735726, DOI: 10.1245/s10434-026-19269-x.Peer-Reviewed Original ResearchPIK3CA Mutations in Early-Onset Appendiceal Adenocarcinoma
Gupta P, Gujarathi R, Qiao L, Godfrey E, Schultz K, Butensky S, Bader J, Sundar R, Cecchini M, Shergill A, Sheltzer J, Turaga K. PIK3CA Mutations in Early-Onset Appendiceal Adenocarcinoma. JCO Precision Oncology 2026, 10: e2500741. PMID: 41712872, DOI: 10.1200/po-25-00741.Peer-Reviewed Original ResearchConceptsAssociated with worse OSAppendiceal cancerAppendiceal adenocarcinomaOverall survivalMutation profilesMultivariate Cox proportional hazards modelKaplan-Meier survival analysisTime of surgeryAssociated with survivalCox proportional hazards modelsProportional hazards modelLate-onset diseaseMetastatic diseaseMucinous tumorsPIK3CA mutationsMutation statusPrognostic assessmentRetrospective analysisMultivariate analysisAdenocarcinomaTherapeutic strategiesPatientsSurvival analysisHazards modelDemographic featuresConsensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases
Gupta P, Godfrey E, Schultz K, Qiao L, Aguirre N, Bader J, Foote M, Shen J, Shergill A, Cecchini M, Sundar R, Sheltzer J, Turaga K. Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases. Annals Of Surgical Oncology 2026, 1-6. PMID: 41634518, DOI: 10.1245/s10434-025-19057-z.Peer-Reviewed Original ResearchThis study investigates drug sensitivity in colorectal cancer peritoneal metastases, showing CMS4 tumors respond better to mitomycin-C and irinotecan, informing personalized chemotherapy strategies.Deep learning approach for critical exposure during division of the inferior mesenteric artery in colorectal surgery
Bader JM, Sun X, Rosenfelt T, Ramirez-Hardy A, Vitchutripop T, Srinivasan A, Pantel H, Khanna A, Rakita D. Deep learning approach for critical exposure during division of the inferior mesenteric artery in colorectal surgery. J Robotic Surg 2026, 20: 155. DOI: 10.1007/s11701-025-03121-7.Peer-Reviewed Original ResearchDeep learning approach for critical exposure during division of the inferior mesenteric artery in colorectal surgery
Bader J, Sun X, Rosenfelt T, Ramirez-Hardy A, Vitchutripop T, Srinivasan A, Pantel H, Khanna A, Rakita D. Deep learning approach for critical exposure during division of the inferior mesenteric artery in colorectal surgery. Journal Of Robotic Surgery 2026, 20: 155. PMID: 41486401, DOI: 10.1007/s11701-025-03121-7.Peer-Reviewed Original ResearchArtificial intelligenceDeep learning algorithmsDeep learning approachIntraoperative maneuversColorectal surgeryThree-dimensional mesh modelDetection modelLearning algorithmsVariable operating environmentRobotic-assisted low anterior resectionTwo-dimensional anglesLearning approachLow anterior resectionSurgery videosInferior mesenteric arteryMesh modelRobotic-assisted surgeryVideo
2025
Robotic Approach to Multivisceral Resection for Gastrointestinal Stromal Tumor With En Bloc Resection of the Stomach, Distal Pancreas, and Spleen: A Case Report
Bader J, Liu S, Billingsley K. Robotic Approach to Multivisceral Resection for Gastrointestinal Stromal Tumor With En Bloc Resection of the Stomach, Distal Pancreas, and Spleen: A Case Report. Cureus 2025, 17: e96479. PMID: 41384208, PMCID: PMC12691104, DOI: 10.7759/cureus.96479.Peer-Reviewed Original ResearchGastrointestinal stromal tumorsStromal tumorsInvasion of adjacent organsBloc distal pancreatectomyHigh-risk featuresUncomplicated postoperative recoveryInterdisciplinary tumor boardEn-bloc resectionAdjuvant imatinibMultivisceral resectionSurgical resectionDistal pancreatectomyExtraluminal growthIntraoperative findingsBloc resectionMesenchymal neoplasmsAdjacent organsDistal pancreasCase reportIntraoperative challengesTumor boardPostoperative recoveryPartial gastrectomyResectionRobotic approachFrailty and functional decline after elective endovascular abdominal aortic aneurysm repair in octogenarians
Li J, Slade M, Gill T, Bader J, Guzman R, Tonnessen B, Kuwayama D, Dardik A, Cardella J, Ochoa Chaar C. Frailty and functional decline after elective endovascular abdominal aortic aneurysm repair in octogenarians. Journal Of Vascular Surgery 2025, 83: 79-90.e2. PMID: 40835162, PMCID: PMC13005939, DOI: 10.1016/j.jvs.2025.08.011.Peer-Reviewed Original ResearchElective endovascular abdominal aortic aneurysm repairEndovascular abdominal aortic aneurysm repairAbdominal aortic aneurysm repairAortic aneurysm repairModified Frailty IndexFollow-upRisk Analysis IndexRisk factorsAneurysm repairValidation cohortDevelopment cohortEastern Cooperative Oncology Group performance statusAsymptomatic infrarenal abdominal aortic aneurysmFunctional declineInfrarenal abdominal aortic aneurysmVascular Quality Initiative (VQI) databaseFrailty assessmentCongestive heart failureAbdominal aortic aneurysmLong-term mortality riskChronic obstructive pulmonary diseaseFrailty indexObstructive pulmonary diseasePreoperative factorsPreoperative comorbiditiesProlonged Survival in Mesothelioma Patients Without Surgical Resection: A National Cancer Database Analysis
Zhan P, Canavan M, Bader J, Boffa D, Resio B, Woodard G. Prolonged Survival in Mesothelioma Patients Without Surgical Resection: A National Cancer Database Analysis. The Annals Of Thoracic Surgery 2025, 121: 633-642. PMID: 40588180, DOI: 10.1016/j.athoracsur.2025.06.015.Peer-Reviewed Original ResearchNational Cancer DatabaseLong-term survivalSurgical resectionOverall survivalPleural mesotheliomaClinical stage I diseaseCurative-intent surgical resectionNational Cancer Database dataNational Cancer Database AnalysisDiagnosis of malignant pleural mesotheliomaDeclined surgical resectionEpithelioid histological typeChemotherapy-treated patientsNonsurgically treated patientsStage I diseaseMalignant pleural mesotheliomaMultivariate logistic regression modelPropensity-matched cohortPropensity score matchingI diseaseSurvival benefitHistological typeSurgery 2Prolonged survivalCancer Database
Clinical Trials
Current Trials
A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis
IRB ID2000038133RoleSub InvestigatorPrimary Completion Date02/15/2027Recruiting Participants
Academic Achievements & Community Involvement
News
News
- April 27, 2026
Personalized Chemotherapy for Abdominal Cancer: A Q&A with Kiran Turaga
- March 09, 2026
Yale Cancer Center Experts Present Advances in Cancer Research at Major Surgical Meeting
- October 14, 2025
Showcasing the Beauty of Basic Science
- February 05, 2024
Surgical Education Solutions: Grant Recipients Announced
Get In Touch
Contacts
Email
Events
May 202619Tuesday
Organization Only Justin "Jay" Bader, MD - Shahyan Ur Rehman, MDZoom details sent via Outlook